Merck & Stock
Merck & Co., Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Country
- United States
- CEO
- Robert Davis
- Employees
- 75,000
- Market cap
- $79.9 B
- IPO
- 08/01/2026
Merck & Co., Inc. is a healthcare company headquartered in Rahway, USA. Founded in 1891, the company employs approximately 75,000 employees and operates within the Drug Manufacturers - General industry. The company provides health solutions through prescription medicines, vaccines, biologic therapies, animal health…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Merck & stock: price history
1D
+0.3%
1W
+0.2%
1M
+0.4%
6M
+21.6%
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Merck &
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
12,463
Dividends
Comparable stocks
Frequently asked questions about Merck & stock
What does Merck & do?
Merck & Co., Inc. is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in United States.
The CEO is Robert Davis, the company employs around 75,000 people.
The IPO was on 08/01/2026; the stock trades on TSX under the ticker MRK.TO.
Does Merck & pay a dividend?
Yes. The last dividend was CA$0.19 per share, ex-date 15/09/2026, paid on 15/10/2026.
Which stocks are comparable to Merck &?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Amgen, Gilead Sciences, Pfizer and Bristol-Myers Squibb Company.
How can I get Merck & stock analyzed?
Clicking "Analyze stock" lets five strategies assess Merck & against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.